XOMA

$36.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.23 (+3.47%) As of 6:04 PM UTC today

Why Robinhood?

You can buy or sell XOMA and other stocks, options, and ETFs commission-free!

About XOMA

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab.

CEO
James R. Neal
Employees
10
Headquarters
Emeryville, California
Founded
1981
Market Cap
433.92M
Price-Earnings Ratio
45.97
Dividend Yield
—
Average Volume
44.49K
High Today
$36.96
Low Today
$35.30
Open Price
$35.30
Volume
7.52K
52 Week High
$46.32
52 Week Low
$15.48

XOMA Earnings

-$0.49
$0.11
$0.72
$1.32
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, Pre-Market

You May Also Like

ACII
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure